Profil
Seiji Miyahara currently works at Taiho Ventures LLC, as Partner & Senior Investment Director from 2024, hC Bioscience, Inc., as Director, and EpiBiologics, Inc., as Director from 2023.
Dr. Miyahara received his doctorate degree from Hokkaido University.
Postes actifs de Seiji Miyahara
| Sociétés | Poste | Début |
|---|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, therapeutic, pharmaceutical, and health sectors. It participates in early stage capital requirements. | Private Equity Investor | 01/07/2016 |
Hc Bioscience, Inc.
Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapy drugs | Directeur/Membre du Conseil | - |
EpiBiologics, Inc.
EpiBiologics, Inc. BiotechnologyHealth Technology Develops antibodies to degrade disease causing proteins | Directeur/Membre du Conseil | 20/07/2023 |
Formation de Seiji Miyahara
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hokkaido University
Hokkaido University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, therapeutic, pharmaceutical, and health sectors. It participates in early stage capital requirements. | Finance |
Hc Bioscience, Inc.
Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapy drugs | Health Technology |
EpiBiologics, Inc.
EpiBiologics, Inc. BiotechnologyHealth Technology Develops antibodies to degrade disease causing proteins | Health Technology |
















